QX
Quang X Pham sold $70K of CVKD stock
Quang X Pham, Chairman, CEO and Interim CFO, 10% of Cadrenal Therapeutics, Inc. (CVKD), sold 18,124 shares of CVKD stock worth $70K, per an SEC Form 4 filed Jun 16, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Jun 11, 2026, 5 days before it was made public.
CVKD has moved -57.8% since the trade date, from $4.03 to $1.70 (Nov 20, 2026 close).
- Traded
- Jun 11, 2026
- Disclosed
- Jun 16, 2026
- Filing delay
- 5 days
- Price since
- -57.8%
- Role
- Chairman, CEO and Interim CFO, 10%
- Source
- SEC Form 4